Sort
15,842 grants matching “pancreatic cancer”
Novel Small Molecule MDM2 Inhibitors for Pancreatic Cancer Therapy
$491,695Ruiwen Zhang · University Of Houston · R01 · FY2018 · CA
Fatty Acylation of Hedgehog and Wnt Proteins
$491,356Marilyn D Resh · Sloan-Kettering Inst Can Research · R01 · FY2018 · GM
IDENTIFICATION OF LNCRNAS REQUIRED FOR SYNTHETIC LETHAL INTERACTIONS WITH MUTANT KRAS IN PANCREATIC CANCER
$490,974University Of Mississippi Medical Center · · FY2018 · Defense Health Agency
(PQD3)Molecular Profiles associated with Long-Term Survival in pancreas Cancer
$490,967Nita Ahuja · Johns Hopkins University · R01 · FY2015 · CA
Pancreatic Cancer Protein Biomarkers for Early Detection
$490,909Teresa A Brentnall · University Of Washington · R01 · FY2010 · CA
Inhibitors of Oxidative Protein Folding For The Treatment of Cancer
$490,849Nathan G. Dolloff · Medical University Of South Carolina · R01 · FY2023 · CA
Inhibitors of Oxidative Protein Folding For The Treatment of Cancer
$490,849Nathan G. Dolloff · Medical University Of South Carolina · R01 · FY2022 · CA
Targeting stem-like cells and their niche in pancreatic cancer
$490,849Tuomas Tammela · Sloan-Kettering Inst Can Research · R37 · FY2025 · CA
Characterization of Cancer Stem Cells
$490,842William Farrar · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Investigating the roles of extracellular cGAMP and harnessing it for cancer treatment
$490,632Aaron F Straight · Stanford University · R01 · FY2023 · CA
Investigating the roles of extracellular cGAMP and harnessing it for cancer treatment
$490,632Lingyin Li · Stanford University · R01 · FY2022 · CA
Targeting stem-like cells and their niche in pancreatic cancer
$490,568Tuomas Tammela · Sloan-Kettering Inst Can Research · R37 · FY2020 · CA
Co-targeting BET Bromodomain Proteins and MNK Kinases in Pancreatic Cancer
$490,514Hidayatullah G Munshi · Northwestern University At Chicago · R01 · FY2025 · CA
Co-targeting BET Bromodomain Proteins and MNK Kinases in Pancreatic Cancer
$490,514Hidayatullah G Munshi · Northwestern University At Chicago · R01 · FY2022 · CA
COMBINING TROP2-DIRECTED CAR-NK CELLS WITH HIF2A INHIBITION FOR THE IMMUNOTHERAPY OF PANCREATIC CANCER
$490,500The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2025 · Defense Health Agency
Pancreatic Cancer Protein Biomarkers for Early Detection
$490,287Teresa A Brentnall · University Of Washington · R01 · FY2009 · CA
Repolarizing the Tumor and Metastatic Microenvironments to Treat Patients with Pancreatic Cancer
$490,237Scott Andrew Gerber · University Of Rochester · R01 · FY2024 · CA
DISRUPTING COLLAGEN-MEDIATED PROSURVIVAL PATHWAYS IN PANCREATIC CANCER
$489,839Wayne State University · · FY2018 · Department of the Army
Stimuli-responsive mucin1-specific nanoparticles for efficacious combinatorial chemotherapy of pancreatic ductal adenocarcinoma
$489,818Juan Luis Vivero-Escoto · University Of North Carolina Charlotte · R01 · FY2025 · CA
The Development And Progression Of IPMN To PDA In The Context Of Inactivated Activin Signaling
$489,796Gloria Huei-Ting Su · Columbia University Health Sciences · R01 · FY2018 · CA
Race,Treatment and Endometrial Cancer Survival
$489,671University Of Pennsylvania · R01 · FY2005 · CA
Highly Specific and Efficient Vectors for Targeting Pancreatic Cancer
$489,556Kimberly A. Kelly · University Of Virginia · R01 · FY2017 · CA
Highly Specific and Efficient Vectors for Targeting Pancreatic Cancer
$489,556Kimberly A. Kelly · University Of Virginia · R01 · FY2016 · CA
Highly Specific and Efficient Vectors for Targeting Pancreatic Cancer
$489,556Kimberly A. Kelly · University Of Virginia · R01 · FY2015 · CA
Combined radiation acoustics and ultrasound imaging for real-time guidance in radiotherapy
$489,551Issam M. El Naqa · H. Lee Moffitt Cancer Ctr & Res Inst · R37 · FY2022 · CA